These data are consistent with pro-inflammatory monocyte infiltration of tumors after radiation13 and also indicate a loss of tumor-resident MHC II+, FOLR2+ macrophages that efficiently prime effector CD8+ T cells and are associated with tumor control and patient survival14,15 (Figures 3F–3H). The gene discussed is CD8A; the disease is neoplasm.